乳腺癌T2*弛豫时间的估算:与临床、影像及病理特征的相关性
研究纳入2011年1月至2013年7月间107例连续女性乳腺癌患者(107个病灶),在3T临床磁共振系统上行多回波T2*加权成像,估算乳腺癌T2*弛豫时间并分析其与临床-影像-病理特征的关系。结果显示浸润性癌平均T2*值显著长于导管原位癌(p=0.029),且在浸润性癌中,T2WI高信号强度及高组织学分级与更长的T2*弛豫时间显著相关。作者认为基于这些初步数据,定量T2* mapping可能有助于乳腺癌的 characterization。
要点
- 浸润性癌平均T2*值显著长于导管原位癌(p=0.029)。
- 浸润性癌中T2WI信号强度越高,T2*弛豫时间越长(p=0.005)。
- 浸润性癌组织学分级越高,T2*弛豫时间越长(p=0.017)。
核心结论
- 浸润性癌的T2*值显著长于导管原位癌;在浸润性癌中,组织学分级越高及T2WI信号强度越高,T2*弛豫时间显著越长,定量T2* mapping基于初步数据可能有助于乳腺癌的 characterization。
研究设计与样本
- 2011年1月至2013年7月间纳入107例连续女性乳腺癌患者(107个乳腺癌病灶),在3T临床磁共振成像系统上行多回波T2*加权成像;采用Student t检验和单因素方差分析比较不同临床-影像-病理特征组的T2*值,并行多元线性回归分析寻找与T2*值相关的独立预测因素。
关键影像表现/征象
- 107个乳腺癌中92个为浸润性癌、15个为导管原位癌(DCIS)。
- 浸润性癌的平均T2*值显著长于DCIS(p=0.029)。
- T2WI信号强度较高的乳腺癌组显示更长的T2*弛豫时间(p=0.005)。
- 组织学分级较高的乳腺癌组显示更长的T2*弛豫时间(p=0.017)。
诊断标准与关键数值
- 以多回波T2*加权成像估算乳腺癌T2*弛豫时间,比较浸润性癌与DCIS的T2*值:浸润性癌平均T2*值显著长于DCIS(p=0.029)。
- 在浸润性癌中,T2WI信号强度与组织学分级在单因素及多因素分析中均与T2*弛豫时间显著相关。
临床应用与阅片要点
- 阅片时可关注乳腺癌病灶的T2WI信号强度,高信号强度与更长的T2*弛豫时间相关。
- 浸润性癌组织学分级越高,T2*弛豫时间越长。
- 定量T2* mapping基于初步数据可能有助于乳腺癌的 characterization。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to estimate the T2* relaxation time in breast cancer, and to evaluate the association between the T2* value with clinical-imaging-pathological features of breast cancer.
MATERIALS AND METHODS: Between January 2011 and July 2013, 107 consecutive women with 107 breast cancers underwent multi-echo T2*-weighted imaging on a 3T clinical magnetic resonance imaging system. The Student's t test and one-way analysis of variance were used to compare the T2* values of cancer for different groups, based on the clinical-imaging-pathological features. In addition, multiple linear regression analysis was performed to find independent predictive factors associated with the T2* values.
RESULTS: Of the 107 breast cancers, 92 were invasive and 15 were ductal carcinoma in situ (DCIS). The mean T2* value of invasive cancers was significantly longer than that of DCIS (p = 0.029). Signal intensity on T2-weighted imaging (T2WI) and histologic grade of invasive breast cancers showed significant correlation with T2* relaxation time in univariate and multivariate analysis. Breast cancer groups with higher signal intensity on T2WI showed longer T2* relaxation time (p = 0.005). Cancer groups with higher histologic grade showed longer T2* relaxation time (p = 0.017).
CONCLUSION: The T2* value is significantly longer in invasive cancer than in DCIS. In invasive cancers, T2* relaxation time is significantly longer in higher histologic grades and high signal intensity on T2WI. Based on these preliminary data, quantitative T2* mapping has the potential to be useful in the characterization of breast cancer.
引用
- Seo M, Ryu JK, Jahng GH, et al. Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features. Korean J Radiol. 2017. PMID: 28096732. doi:10.3348/kjr.2017.18.1.238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。